New-Onset Diabetes in Covid-19

Francesco Rubino, Stephanie Amiel, Paul Z. Zimmet, Kurt George Alberti, Stefan Bornstein, Robert H. Eckel, Geltrude Mingrone, Bernhard Boehm, Mark Cooper, zhonglin chai, Stefano Del Prato, Linong Ji, David Hopkins, William Herman, Kamlesh Khunti, Jean Claude N. Mbanya, Eric Renard

Research output: Contribution to journalLetterpeer-review

541 Citations (Scopus)
103 Downloads (Pure)

Abstract

There is a bidirectional relationship between Covid-19 and diabetes. On the one
hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, newonset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19.1-3
These manifestations of diabetes pose challenges in clinical management and suggest a complex pathophysiology of Covid-19–related diabetes.
Original languageEnglish
Pages (from-to)789-791
Number of pages3
JournalNew England Journal of Medicine
Volume383
Issue number8
Early online date12 Jun 2020
DOIs
Publication statusPublished - 20 Aug 2020

Keywords

  • diabetes, COVID-19, SARS-Cov-2, DKA

Fingerprint

Dive into the research topics of 'New-Onset Diabetes in Covid-19'. Together they form a unique fingerprint.

Cite this